Skip to main content
SpringerLink
Log in

Breast Cancer Screening

  • Chapter
Management of Breast Diseases

  • 1948 Accesses

Abstract

In our society, there is a deeply rooted belief that the early detection of cancer is invariably beneficial, and evidence to the contrary is often viewed with skepticism. Today, several breast cancer screening methods are available, and it is important that we evaluate these critically and base screening recommendations on good evidence rather than assumptions. To realize how assumptions about cancer screening can be misleading, consider the history of lung cancer screening. For many years, it was assumed that screening for lung cancer with sputum cytology or chest radiographs would be beneficial. Eventually, four randomized prospective trials showed that this assumption was wrong [1]. Thus, we do not routinely recommend lung cancer screening today, although additional trials examining its efficacy are ongoing. The example of lung cancer screening serves to illustrate why it is necessary to first obtain evidence concerning the efficacy of cancer screening, before implementing it into clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eddy DM (1989) Screening for lung cancer. Ann Intern Med. 111:232–7

    CAS  PubMed  Google Scholar 

  2. MacDonald I (1951) Biological predeterminism in human cancer. Surg Gynecol Obstet. 92:443–52

    CAS  PubMed  Google Scholar 

  3. Black MM, Speer FD (1953) Biological variability of breast carcinoma in relation to diagnosis and therapy. NY State J Med. 53:1560–3

    CAS  Google Scholar 

  4. Devitt JE (1994) Breast cancer: have we missed the forest because of the tree? Lancet. 344:734–5

    CAS  PubMed  Google Scholar 

  5. Haagensen CD (1956) Diseases of the breast. WB Saunders, Philadelphia

    Google Scholar 

  6. Jatoi I (1999) Breast cancer screening. Am J Surg. 177:518–24

    CAS  PubMed  Google Scholar 

  7. Jatoi I (1997) Breast cancer: a systemic or local disease? Am J Clin Oncol. 20:536–9

    CAS  PubMed  Google Scholar 

  8. Cole P, Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst. 64:1263–72

    CAS  PubMed  Google Scholar 

  9. Nielsen C, Lang RS (1999) Principles of screening. Med Clin North Am. 83:1323–37

    CAS  PubMed  Google Scholar 

  10. Anderson TJ, Lamb J, Alexander F et al (1986) Comparative pathology of prevalent and incident cancers detected by breast cancer screening: Edinburgh breast screening project. Lancet. 1:519–23

    CAS  PubMed  Google Scholar 

  11. Gilliland FD, Joste N, Stauber PM et al (2000) Biologic characteristics of interval and screen-detected breast cancer. J Natl Cancer Inst. 92:743–9

    CAS  PubMed  Google Scholar 

  12. Xu IL, Prorok PC (1995) Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases. Stat Med. 14:2715–25

    CAS  PubMed  Google Scholar 

  13. Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med. 328:1237–43

    CAS  PubMed  Google Scholar 

  14. Kiemi PJ, Joensuu H, Toikkanen S et al (1992) Aggressiveness of breast cancers found with and without screening. Br Med J. 304:467–9

    Google Scholar 

  15. Schmidt JG (1990) The epidemiology of mass breast cancer screening — a plea for a valid measure of benefit. J Clin Epidemiol. 43:215–22

    CAS  PubMed  Google Scholar 

  16. Monsees BS, Destouet JM (1992) A screening mammography program: staying alive and making it work. Radiol Clin North Am. 30:211–9

    CAS  PubMed  Google Scholar 

  17. Hurley SF, Kaldor JM (1992) The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev. 14:101–30

    CAS  PubMed  Google Scholar 

  18. Salomon A (1913) Beitrage zur pathologie und klinik der maminacrcinome. Arch f klin Chir. 101:573–668

    Google Scholar 

  19. Warren SL (1930) A roentgenologic study of the breast, Am J Roentgenol. 24:113–24

    Google Scholar 

  20. Gershon-Cohen I, Ingleby H, Moore L (1956) Can mass X-ray surveys be used in detection of early cancer of the breast? JAMA. 161:1069–71

    CAS  Google Scholar 

  21. Gershon-Cohen I, Hermel MB, Berger SM (1961) Detection of breast cancer by periodic X-ray examinations. JAMA. 176:1114–6

    CAS  PubMed  Google Scholar 

  22. Egan RL (1962) Mammography, an aid to diagnosis of breast carcinoma. JAMA. 182:839–43

    Google Scholar 

  23. Fletcher SW, Black W, Harris R et al (1993) Report of the international workshop on screening for breast cancer. J Natl Cancer Inst. 85:1644–56

    CAS  PubMed  Google Scholar 

  24. Shapiro S, Venet W, Strax P et al (1982) Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 69:349–55

    CAS  PubMed  Google Scholar 

  25. Eddy DM, Hasselblad V, McGivney W et al (1988) The value of mammography screening in women under age 50 years. JAMA. 259:1512–9

    CAS  PubMed  Google Scholar 

  26. Shapiro S, Venet W, Strax P et al. (1988) Periodic screening for breast cancer: the Health Insurance Plan Project and Its Sequelae, 1963–1986. Johns Hopkins University, Baltimore

    Google Scholar 

  27. Nystrom L, Rutqvist LE, Wall S et al (1993) Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet. 341:973–8

    CAS  PubMed  Google Scholar 

  28. Organizing Committee and Collaborators (1996) Breast cancer screening with mammography in women aged 40–49 years: report of the Organizing Committee and Collaborators, Falun Meeting, Falun, Sweden (21 and 22 March 1996). Int J Cancer. 68:693–9

    Google Scholar 

  29. Hendrick RE, Smith RA, Rutlege JH et al (1997) Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst. 22:87–92

    PubMed  Google Scholar 

  30. Alexander FE, Anderson TI, Brown H et al (1994) The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer. 70:542–8

    CAS  PubMed  Google Scholar 

  31. Alexander FE (1997) The Edinburgh randomized trial of breast cancer screening. Monogr Natl Cancer Inst. 22: 31–5

    PubMed  Google Scholar 

  32. Alexander FE, Anderson TI, Brown HK et al (1999) 14 years of follow-up from the Edinburgh randamised trial of breast cancer screening. Lancet. 353:1903–8

    CAS  PubMed  Google Scholar 

  33. Miller AB, Baines CI, To T et al (1992) Canadian national breast screening study I. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J. 147:1459–76

    CAS  Google Scholar 

  34. Miller AB, Baines CJ, To T et al (1992) Canadian national breast screening study II. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 147:1477–88

    CAS  Google Scholar 

  35. Miller AB, To T, Baines CI, Wall C (2000) Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst. 92:1490–9

    CAS  PubMed  Google Scholar 

  36. Mosss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L (2006) Trial management group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomized controlled trial. Lancet. 368(9552):2053–60

    Google Scholar 

  37. Kerlikowske K, Grady D, Rubin SM et al (1995) Efficacy of screening mammography. A meta-analysis. JAMA. 273: 149–54

    CAS  PubMed  Google Scholar 

  38. Smart CR, Hendrick RE, Rutledge JH III et al (1995) Benefit of mammography screening in women ages40 to 49 years: current evidence from randomized controlled trials. Cancer. 75:1619–25

    CAS  PubMed  Google Scholar 

  39. Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 137: 347–60

    PubMed  Google Scholar 

  40. Gotzsche PC, Olsen O (2000) Is screening for breast cancer with mamography justifiable? Lancet. 355:129–34

    CAS  PubMed  Google Scholar 

  41. Duffy SW, Tabar L (2000) Screening mammography re-evaluated. Lancet. 355:747–8

    CAS  PubMed  Google Scholar 

  42. Dean PB (2000) Final comment. The articles by Gotzsche and Olsen are not Official Cochrane reviews and lack scientific merit. Lakartidningen. 97:3106

    CAS  PubMed  Google Scholar 

  43. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2006;(4): CD001877

    PubMed  Google Scholar 

  44. Jatoi I (1997) The case against mammographic screening for women in their forties. In: Jatoi I (ed) Breast cancer screening. Landes Biosciences, Austin, TX, pp 35–49

    Google Scholar 

  45. Jatoi I, Baum M (1993) American and European recommendations for screening mammography in younger women: a cultural divide? RMJ. 307:1481–3

    CAS  Google Scholar 

  46. Davis DL, Love SM (1994) Mammographic screening. JAMA. 271:152–3

    CAS  PubMed  Google Scholar 

  47. Fletcher SW (1997) Breast cancer screening among women in their forties: an overview of the issues. Monogr Natl Cancer Inst. 22:5–9

    PubMed  Google Scholar 

  48. Kerlikowske K (1997) Efficacy of screening mammography among women aged 40 to 49 years and 40 to 69 years: comparison of relative and absolute benefit. Monogr Natl Cancer Inst. 22:79–86

    PubMed  Google Scholar 

  49. de Koning HJ, Boer R, Warmerdam PG et al (1995) Quantitative interpretations of age-specific mortality reductions from the Swedish breast cancer screening trials. J Nati Cancer Inst. 87:1217–23

    Google Scholar 

  50. Kopans DB (1997) The case in favor of mammographic screening for women in their forties. In: Jatoi I (ed) Breast cancer screening. Landes Biosciences, Austin, TX, pp 9–34

    Google Scholar 

  51. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials. 1993 (Doc No. 32)

    Google Scholar 

  52. Clemmensen J (1948) Carcinoma of the breast: results from statistical research. Br J Radiol. 21:583

    Google Scholar 

  53. Jatoi I, Anderson WF, Rosenberg PS (2008) Qualitative age-interactions in breast cancer: a tale of two diseases? Am J Clin Oncol. 31:504–6

    PubMed  Google Scholar 

  54. Willett W (1990) Nutritional epidemiology. Oxford University, New York

    Google Scholar 

  55. Henderson IC (1992) Biologic variations of tumors. Cancer. 69:1888–95

    CAS  PubMed  Google Scholar 

  56. Baines CJ (2003) Mammography screening: are women really giving informed consent? J Natl Cancer Inst. 95(20): 1512–3

    PubMed  Google Scholar 

  57. Tabar L, Fagerberg G, Day NE et al (1987) What is the optimum interval between mammographic screening examinations? An analysis based on the lates results of the Swedish two-county breast cancer screening trial. Br J Cancer. 55:547–51

    CAS  PubMed  Google Scholar 

  58. Leitch AM, Dodd GD, Constanza M et al (1997) American cancer society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin. 47:150–3

    CAS  PubMed  Google Scholar 

  59. Larsson LG, Nystrom L, Wall S et al (1996) The Swedish randomized mammography screening trials. J Med Screen. 3:129–32

    CAS  PubMed  Google Scholar 

  60. Kerlikowske K, Salzmann P, Phillips KA et al (1999) Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 282:2156–63

    CAS  PubMed  Google Scholar 

  61. Kuhl CK (2008) The “coming of age” of nonmammographic screening for breast cancer. JAMA. 299(18):2203–5

    CAS  PubMed  Google Scholar 

  62. Berg WA, Blume JD, Cormack JB (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 299(18):2151–63

    CAS  PubMed  Google Scholar 

  63. Tohno E, Ueno E, Watanabe H (2009) Ultrasound screening of breast cancer. Breast Cancer. 16(1):18–22

    PubMed  Google Scholar 

  64. Jatoi I, Anderson WF (2008) Management of women who have a genetic predisposition for breast cancer. Surg Clin North Am. 88(4):845–61

    PubMed  Google Scholar 

  65. Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med. 351(5):427–37

    CAS  PubMed  Google Scholar 

  66. Saslow D, Boetes C, Burke W et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 57(2):75–89

    PubMed  Google Scholar 

  67. Bums RB, Freund KM, Ash AS et al (1996) As mammography use increases, are some providers omitting clinical breast examination? Arch Intern Med. 156:741–4

    Google Scholar 

  68. Saslow D, Hannan J, Osuch J et al (2004) Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin. 54: 327–44

    PubMed  Google Scholar 

  69. Mittra I, Baum M, Thornton H et al (2000) Is clinical breast examination an acceptable alternative to mammographic screening? BMJ. 321:1071–3

    CAS  PubMed  Google Scholar 

  70. Report of the Working Group to review the National Cancer Institute-American Cancer Society breast cancer detection demonstration projects. J Nati Cancer Inst. 1979;62: 639–709

    Google Scholar 

  71. Pisani P, Parkin DM, Ngelangel C, Esteban D et al (2006) Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 118(1):149–54

    CAS  PubMed  Google Scholar 

  72. Barton MB, Harris R, Fletcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 282:1270–80

    CAS  PubMed  Google Scholar 

  73. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database of Systematic Reviews 2003, issue 2. Art. No. CD003373, DOI: 10.1002/14651858.CD003373

    Google Scholar 

  74. Adair FE (1933) Clinical manifestations of early cancer of the breast — with a discussion on the subject of biopsy. N Engl J Med. 208:1250–5

    Article  Google Scholar 

  75. Semiglazov VF, Moiseyenko VM, Bavli JL, Migmanova N et al (1992) The role of breast self-examination in early breast cancer detection (results of the 5-year USSR/WHO randomized study in Leningrad). Eur J Epidemiol. 8(4):498–502

    CAS  PubMed  Google Scholar 

  76. Semiglazov VF, Moiseyenko VM, Manikhas AG, Protsenko SA, Kharikova RS, Ivanow VG et al (1999) Role of breast selfexamination in early detection of breast cancer: Russia/WHO prospective randomized trial in St.Petersburg. Cancer Strategy, 1:145–51

    Google Scholar 

  77. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL et al (2002) Randomized trial of breast self-examination: final results. J Natl Cancer Inst. 94(19):1445–57

    PubMed  Google Scholar 

  78. Fletcher SW, Elmore JG (2005) False-positive mammograms — can the USA learn from Europe? Lancet. 365:7–8

    PubMed  Google Scholar 

  79. Elmore JG, Barton MB, Moceri VM et al (1998) Ten-year risk of false-positive screening mammograms and clinical breast examinations. N Engl J Med. 338:1089–96

    CAS  PubMed  Google Scholar 

  80. Hofvind S, Thorsen S, Tretli S (2004) The cumulative risk of a false-positive recall in the Norwegian breast cancer screening program. Cancer. 101:1501–7

    PubMed  Google Scholar 

  81. Schwartz LM, Woloshin S, Sox HC et al (2000) U.S. women’s attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 320:1635–40

    CAS  PubMed  Google Scholar 

  82. Jatoi I, Zhu K, Shah M, Lawrence W (2006) Psychological distress in U.S. women who have experienced false-positive mammograms. Breast Cancer Res Treat. 101:191–200

    Google Scholar 

  83. Bailar JC (1976) Mammography: a contrary view. Ann Intern Med. 84:77–84

    PubMed  Google Scholar 

  84. Beemsterboer PM, Warmerdam PG, Boer R et al (1998) Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 5:81–7

    CAS  PubMed  Google Scholar 

  85. Swift M, Morrell D, Massey RB et al (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 325:1831–6

    Article  CAS  PubMed  Google Scholar 

  86. Werneke U (1997) Ataxia telangiectasia and risk of breast cancer. Lancet. 350:739–40

    CAS  PubMed  Google Scholar 

  87. Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med. 357(2):154–62

    CAS  PubMed  Google Scholar 

  88. Vaidya JS, Baum M (1997) Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. JAMA. 278:290

    CAS  PubMed  Google Scholar 

  89. de Gonzalez AM, Berg CD, Visvanathan K, Robson M (2009) Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst. 101:205–9

    Google Scholar 

  90. Peeters PH, Verbeek AL, Straatman H et al (1989) Evaluation of over-diagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol. 18:295–9

    CAS  PubMed  Google Scholar 

  91. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP (2006) Rate of over-diagnosis of breast cancer 15 years after end of malmo mammographic screening trial: follow-up study. Br Med J. 332(7543):689–92

    Google Scholar 

  92. Zahl P, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 168(21):2311–6

    PubMed  Google Scholar 

  93. Jatoi I, Baum M (1995) Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery. 118:118–20

    CAS  PubMed  Google Scholar 

  94. Welch HG, Woloshin S, Schwartz LM (2008) The sea of uncertainty surrounding ductal carcinoma in situ — the price of screening mammography. J Natl Cancer Inst. 100(4): 228–9

    PubMed  Google Scholar 

  95. Moore MM (1991) Treatment of ductal carcinoma in situ of the breast. Semin Surg Oncol. 7:267–70

    CAS  PubMed  Google Scholar 

  96. Emster VL, Barclay J, Kerlikowske K et al (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 275:913–8

    Google Scholar 

  97. Nielsen M, Thomsen JL, Primdahl S et al (1987) Breast cancer and atypia among young and middle aged women: a study of 110 medicolegal autopsies. Br J Cancer. 56: 814–9

    CAS  PubMed  Google Scholar 

  98. Rosen PR, Braun DW Jr, Kinne DE (1980) The clinical significance of pre-invasive breast carcinoma. Cancer. 46:919–25

    CAS  PubMed  Google Scholar 

  99. Page DL, Dupont WD, Rogers LW et al (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 49:751–8

    CAS  PubMed  Google Scholar 

  100. Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol. 16:796–807

    CAS  PubMed  Google Scholar 

  101. Kattlove H, Liberati A, Keeler B et al (1995) Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package. JAMA. 273: 142–8

    CAS  PubMed  Google Scholar 

  102. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ (2008) Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 100:1290–300

    PubMed  Google Scholar 

  103. Black WC, Nease RF, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 87:720–31

    CAS  PubMed  Google Scholar 

  104. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 353(17):1784–92

    CAS  PubMed  Google Scholar 

  105. Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol. 25(13):1683–90

    PubMed  Google Scholar 

  106. Jatoi I, Anderson WF, Rao SR, Devesa SS (2006) Breast cancer trends among black and white women in the United States. J Clin Oncol. 23(31):7836–41

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Care Center, National Naval Medical Center, Uniformed Services University, Bethesda, MD, 20889, USA

    Ismail Jatoi

Authors
  1. Ismail Jatoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Breast Care Center National Naval Medical Center, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD, 20814, USA

    Ismail Jatoi (Head) (Head)

  2. Women’s Hospital, University of Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany

    Manfred Kaufmann (Breast Unit Director) (Breast Unit Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jatoi, I. (2010). Breast Cancer Screening. In: Jatoi, I., Kaufmann, M. (eds) Management of Breast Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69743-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69743-5_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69742-8

  • Online ISBN: 978-3-540-69743-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation